Background/Aims: Impairment in executive function is associated with a heightened risk for falls in people with mild cognitive impairment (MCI) and dementia. The purpose of this study was to determine which aspects of executive function are associated with falls risk. Methods: Forty-two participants with a mean age of 81.6 years and a diagnosis of MCI or mild dementia completed five different executive function tests from the computerised CANTAB test battery and a comprehensive falls risk assessment. Results: A hierarchical regression analysis showed that falls risk was significantly associated with spatial memory abilities and inhibition of a pre-potent response. Conclusion: The concept of executive function may be too general to provide meaningful results in a research or clinical context, which should focus on spatial memory and inhibition of a pre-potent response.

1.
Muir SW, Gopaul K, Montero Odasso MM: The role of cognitive impairment in fall risk among older adults: a systematic review and meta-analysis. Age Ageing 2012;41:299-308.
2.
Kearney FC, Harwood RH, Gladman JR, Lincoln N, Masud T: The relationship between executive function and falls and gait abnormalities in older adults: a systematic review. Dement Geriatr Cogn Disord 2013;36:20-35.
3.
Mirelman A, Herman T, Brozqol M, Dorfman M, Sprecher E, Schweiger A, Giladi N, Hausdorff JM: Executive function and falls in older adults: new findings from a five-year prospective study link fall risk to cognition. PLoS One 2012;7:e40297.
4.
Lezak MD, Howieson DB, Loring DW (eds): Neuropsychological Assessment. New York, Oxford University Press, 2004.
5.
Salthouse TA: What cognitive abilities are involved in trail-making performance? Intelligence 2011;39:222-232.
6.
Law LLF, Barnett F, Yau MK, Gray MA: Effects of combined cognitive and exercise interventions on cognition in older adults with and without cognitive impairment: a systematic review. Ageing Res Rev 2014;15:61-75.
7.
Diamond A: Executive functions. Annu Rev Psychol 2013;64:135-168.
8.
Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, Wager TD: The unity and diversity of executive functions and their contributions to complex ‘Frontal Lobe' tasks: a latent variable analysis. Cogn Psychol 2000;41:49-100.
9.
Sheridan PL, Hausdorff JM: The role of higher-level cognitive function in gait: executive dysfunction contributes to fall risk in Alzheimer's disease. Dement Geriatr Cogn Disord 2007;24:125-137.
10.
Chan RCK, Shum D, Toulopoulou T, Chen EYH: Assessment of executive functions: review of instruments and identification of critical issues. Arch Clin Neuropsychol 2008;23:201-216.
11.
Lonie JA, Herrmann LL, Donaghey CL, Ebmeier KP: Clinical referral patterns and cognitive profile in mild cognitive impairment. Br J Psychiatry 2008;192:59-64.
12.
Weintraub S, Wicklund AH, Salmon DP: The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med 2012;2:a006171.
13.
Lafleche G, Albert M-S: Executive function deficits in mild Alzheimer's disease. Neuropychology 1995;9:313-320.
14.
Funahashi S, Andreau JM: Prefrontal cortex and neural mechanisms of executive function. J Physiol Paris 2013;107:471-482.
15.
Kievit RA, Davis SW, Mitchell DJ, Taylor JR, Duncan J; Cam-CAN Research Team, Henson RNA: Distinct aspects of frontal lobe structure mediate age-related differences in fluid intelligence and multitasking. Nat Commun 2014;18:5658.
16.
Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
17.
Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H: The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-699.
18.
Brown J, Pengas G, Dawson K, Brown LA, Clatworthy P: Self-administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study. BMJ 2009;338:B2030.
19.
Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P: Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 1994;5:266-281.
20.
Summers MJ, Saunders NL: Neuropsychological measures predict decline to Alzheimer's dementia from mild cognitive impairment. Neuropsychology 2012;26:498-508.
21.
Alichniewicz KK, Brunner F, Klünemann HH, Greenlee MW: Structural and functional neural correlates of visuospatial information processing in normal aging and amnestic mild cognitive impairment. Neurobiol Aging 2012;33:2782-2797.
22.
Klekociuk SZ, Summers JJ, Vickers JC, Summers MJ: Reducing false positive diagnoses in mild cognitive impairment: the importance of comprehensive neuropsychological assessment. Eur J Neurol 2014;21:1330-1336.
23.
Lord SR, Menz HB, Tiedemann A: A physiological profile approach to falls risk assessment and prevention. Phys Ther 2003;83:237-252.
24.
Van Iersel MB, Munneke M, Esselink RA, Benraad CE, Olde Rikkert MG: Gait velocity and the Timed-Up-and-Go test were sensitive to changes in mobility in frail elderly patients. J Clin Epidemiol 2008;61:186-191.
25.
Christofoletti G, Oliani MM, Gobbi S, Stella F, Bucken Gobbi LT, Renato Canineu P: A controlled clinical trial on the effects of motor intervention on balance and cognition in institutionalized elderly patients with dementia. Clin Rehabil 2008;22:618-626.
26.
Soper D: Post-hoc statistical power calculator for hierarchical multiple regression. http://www.danielsoper.com/statcalc (accessed January 19, 2015).
27.
Ballard CG, Shaw F, Lowrey K, McKeith I, Kenny R: The prevalence, assessment and associations of falls in dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 1999;10:97-103.
28.
Kosse NM, De Groot MH, Vuillerme N, Hortobagyi T, Lamoth CJ: Factors related to high fall rate in long-term care residents with dementia. Int Psychogeriatr 2015;27:803-84.
29.
Härlein J, Dassen T, Halfens RJG, Heinze C: Fall risk factors in older people with dementia or cognitive impairment: a systematic review. J Adv Nurs 2009;65:922-933.
30.
Ley P: Quantitative aspects of psychological assessment, 2007. http://www.psychassessment.com.au/PDF/mod5.pdf (accessed January 19, 2015).
31.
Makizako H, Shimada H, Doi T, Park H, Yoshida D, Uemura K, Tsutsumimoto K, Liu-Ambrose T, Suzuki T: Poor balance and lower grey matter volume predict falls in older adults with mild cognitive impairment. BMC Neurol 2013;5:102.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.